Racial and ethnic differences in treatment and outcomes of severe aortic stenosis: a review
JB Wilson, LR Jackson, FE Ugowe, T Jones… - Cardiovascular …, 2020 - jacc.org
Aortic stenosis (AS) is among the most common valvular heart diseases encountered in the
United States. In this review the authors examine differences between racial and ethnic …
United States. In this review the authors examine differences between racial and ethnic …
Patient engagement in research: early findings from the Patient-Centered Outcomes Research Institute
LP Forsythe, KL Carman, V Szydlowski, L Fayish… - Health …, 2019 - healthaffairs.org
Charged with ensuring that research produces useful evidence to inform health decisions,
the Patient-Centered Outcomes Research Institute (PCORI) requires investigators to engage …
the Patient-Centered Outcomes Research Institute (PCORI) requires investigators to engage …
18F-Sodium Fluoride (18F-NaF) for Imaging Microcalcification Activity in the Cardiovascular System
Accumulating preclinical and clinical evidence suggests that calcification is one of the body's
primary responses to injury and a key pathological feature of cardiovascular disease …
primary responses to injury and a key pathological feature of cardiovascular disease …
Detection and prediction of bioprosthetic aortic valve degeneration
Background: Bioprosthetic aortic valve degeneration is increasingly common, often
unheralded, and can have catastrophic consequences. Objectives: The authors sought to …
unheralded, and can have catastrophic consequences. Objectives: The authors sought to …
Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies
MP Winter, P Bartko, F Hofer, M Zbiral, A Burger… - Scientific reports, 2020 - nature.com
Aim of the present analysis was to collect and pool all available data currently in the
literature regarding outcomes and complications of all approved TAVR prosthesis and to …
literature regarding outcomes and complications of all approved TAVR prosthesis and to …
Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome
B Fujita, T Schmidt, S Bleiziffer, T Bauer… - European Journal of …, 2020 - academic.oup.com
OBJECTIVES The purpose of this study was to evaluate the incidence of new pacemaker
implantation (NPMI) after surgical aortic valve replacement (SAVR) and transcatheter aortic …
implantation (NPMI) after surgical aortic valve replacement (SAVR) and transcatheter aortic …
Implementation of transcatheter aortic valve replacement in France
V Nguyen, M Michel, H Eltchaninoff, M Gilard… - Journal of the American …, 2018 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) has emerged as an alternative
to surgical aortic valve replacement (SAVR), but unbiased data regarding evolution of the …
to surgical aortic valve replacement (SAVR), but unbiased data regarding evolution of the …
Perceval sutureless aortic valve implantation: midterm outcomes
D Szecel, R Eurlings, F Rega, P Verbrugghe… - The Annals of Thoracic …, 2021 - Elsevier
Background Because our center participated in the first-in-human trial with Perceval
(LivaNova, Sallugia, Italy) in 2007, this series represents the longest available clinical follow …
(LivaNova, Sallugia, Italy) in 2007, this series represents the longest available clinical follow …
Konsensuspapier der Deutschen Gesellschaft für Kardiologie (DGK) und der Deutschen Gesellschaft für Thorax‑, Herz-und Gefäßchirurgie (DGTHG) zur …
KH Kuck, S Bleiziffer, H Eggebrecht… - Zeitschrift für Herz …, 2020 - search.proquest.com
Abstract Nach den 2 Positionspapieren der Deutschen Gesellschaft für Kardiologie (DGK) in
2015 und 2016 zum Thema der kathetergestützten Aortenklappenimplantation (TAVI) haben …
2015 und 2016 zum Thema der kathetergestützten Aortenklappenimplantation (TAVI) haben …
Multimodal analytical tools to enhance mechanistic understanding of aortic valve calcification
KA Perez, DW Deppe, A Filas, SA Singh… - The American Journal of …, 2024 - Elsevier
This review focuses on technologies at the core of calcific aortic valve disease (CAVD) and
drug target research advancement, including transcriptomics, proteomics, and molecular …
drug target research advancement, including transcriptomics, proteomics, and molecular …